GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
111 hedge funds and large institutions have $266M invested in GenMark Diagnostics, Inc in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 49 increasing their positions, 28 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
111
Holders Change
+1
Holders Change %
+0.91%
% of All Funds
2.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
49
Reduced
28
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$5.05M |
| 2 |
NIM
Needham Investment Management
New York
|
+$2.62M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$2.05M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.78M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.71M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.26M |
| 2 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$2.49M |
| 3 |
Millennium Management
New York
|
-$1.62M |
| 4 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$1.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$988K |
